CIK 0001357874 · Non-accelerated filer<br>Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- operating
- Phone
- 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +8,888 | 124,463 | ||
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +37,069 | 161,532 | ||
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +69,421 | 230,953 | ||
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −8,888 | 0 | ||
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −37,069 | 37,069 | ||
| 2026-01-20 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −69,421 | 69,421 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +1,978 | 30,236 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +8,425 | 38,661 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +14,908 | 53,569 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −1,978 | 0 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −8,425 | 8,425 | ||
| 2026-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −14,908 | 14,907 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise 10b5-1 | +3,888 | 81,186 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise 10b5-1 | +13,900 | 95,086 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise 10b5-1 | +26,575 | 121,661 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,888 | 0 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −13,900 | 13,901 | ||
| 2026-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −26,575 | 26,575 | ||
| 2026-01-20 | SMITH J. JEFFERSON Chief Research Officer | Option exercise 10b5-1 | +2,500 | 93,718 | ||
| 2026-01-20 | SMITH J. JEFFERSON Chief Research Officer | Option exercise 10b5-1 | +10,447 | 104,165 |
Page 3 of 11 · 210 trades